Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ghrelin safety in patients with advanced chronic kidney disease
jRCTs031180354Completed
- Start
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of human ghrelin in chronic kidney disease (CKD). Primary endpoint: Time course of the blood concentration of ghrelin. Started Dec 2015; status: completed.
02
Drugs
human ghrelin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCTs031180354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180354.